The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 billion by 2021 from USD 9.81 billion in 2016, at a CAGR of 15.5% during the forecast period. The report segments the needle-free injection system market based on product, technology, usability, type, site of delivery, applications, end user and regions.
Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.
North America is poised to be fastest-growing region in the needle-free injection system market from 2016 to 2021. High growth in this market is attributed to factors such as the increasing demand for self-administration, and rising prevalence of chronic diseases and conditions (such as heart disease, stroke, cancer, type 2 diabetes, obesity, and arthritis), advantages offer by needle-free injection system are driving market growth.
- Antares Pharma, Inc.
- Bioject Medical Technologies Inc.
- Endo International Plc
- European Pharma Group
- Injex Pharma AG
- Medical International Technology, Inc. (MIT)
- National Medical Products, Inc.
- Penject Corporation
- Valeritas, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Needle-Free Injection System Market, by Product
7 Needle-Free Injection System Market, by Technology
8 Needle-Free Injection System Market, by Type
9 Needle-Free Injection System Market, by Usability
10 Needle-Free Injection System Market, by Site of Delivery
11 Needle-Free Injection System Market, by Application
12 Needle-Free Injection System Market, by End User
13 Needle-Free Injection System Market, by Region
14 Competitive Landscape
15 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/zh37jf/needle_free
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-needle-free-injection-system-market-to-reach-20-billion-by-2021---rising-demand-for-biosimilars--vaccination---research-and-markets-300375972.html
SOURCE Research and Markets